Patents by Inventor Jörg Slaghuis

Jörg Slaghuis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9493736
    Abstract: The present invention relates to a method for the lysis of cells, especially bacterial cells and the isolation of nucleic acids. The sample is treated with lysis solution that comprises at least one liquid that is not miscible with water and heated. Afterwards the mixture is cooled down and water is added so that after cooling a two phase system is generated. The nucleic acids can be found in the aqueous phase.
    Type: Grant
    Filed: March 28, 2012
    Date of Patent: November 15, 2016
    Assignee: MERCK PATENT GMBH
    Inventors: Joerg Slaghuis, Peter Rossmanith, Sabine Fuchs, Patrick Julian Mester, Martin Wagner
  • Publication number: 20140051088
    Abstract: The present invention relates to a method for the lysis of cells, especially bacterial cells and the isolation of nucleic acids. The sample is treated with lysis solution that comprises at least one liquid that is not miscible with water and heated. Afterwards the mixture is cooled down and water is added so that after cooling a two phase system is generated. The nucleic acids can be found in the aqueous phase.
    Type: Application
    Filed: March 28, 2012
    Publication date: February 20, 2014
    Applicant: MERCK PATENT GMBH
    Inventors: Joerg Slaghuis, Peter Rossmanith, Sabine Fuchs, Patrick Julian Mester, Martin Wagner
  • Patent number: 7858595
    Abstract: Neutral straight-chain or branched oligosaccharides for preventing the invasion and infection of mammal cells by pathogens and for fighting diseases caused by such pathogens are disclosed. Food, dietetic products and pharmaceutical agents containing oligosaccharides consist of a base unit of formula (I), and between 0 and 19 other units of formula (II), which are linked directly or indirectly to the base unit. Gal represents a galactose monosaccharide unit; Glc represents a glucose monosaccharide unit; HexNAc rpresents an N-acetylated galactosamine or glucosamine monosaccharide unit (GalNAc or GlcNAc); R independently represent a ? 1-3 or ? 1-6 glycosidic link to HexNAc monosaccharide of the next [Gal-HexNAc] unit (II), and on a terminal [Gal-HexNAc] unit, or R are not present; and a terminal [Gal-HexNAc] unit, wherein R represent a deoxyhexose radical, can have another deoxyhexose radical on the HexNAc monosaccharide unit.
    Type: Grant
    Filed: September 25, 2002
    Date of Patent: December 28, 2010
    Assignee: N.V. Nutricia
    Inventors: Bernd Stahl, Berndt Finke, Joachim Schmitt, Werner Goebel, Jörg Slaghuis